NcRNAs-mediated P2RX1 expression correlates with clinical outcomes and immune infiltration in patients with breast invasive carcinoma.

导出 OA

翻译打印收藏纠错

第一作者： Yiyue,Xu

第一单位： 3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China.

作者： Yiyue,Xu ^[1] ; Bing,Zou ^[2] ; Bingjie,Fan ^[3] ; Butuo,Li ^[4] ; Jinming,Yu ^[5] ; Linlin,Wang ^[6] ; Jin,Zhang ^[6]

作者单位： 3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China. ^[1] Key Laboratory of Breast Cancer Prevention and Therapy of Ministry of Education, Tianjin, P.R. China. ^[2] Key Laboratory of Cancer Prevention and Therapy, Tianjin, P.R. China. ^[3] Tianjin's Clinical Research Center for Cancer, Tianjin, P.R. China. ^[4] Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, P.R. China. ^[5] Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, P.R. China. ^[6]

关键词 P2RX1 breast cancer immune infiltration noncoding RNA prognosis

主题词乳腺肿瘤(Breast Neoplasms);癌(Carcinoma);女(雌)性(Female);人类(Humans);预后(Prognosis)

DOI 10.18632/aging.204087

PMID 35585027

发布时间 2022-07-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交